Molina Healthcare Stock Dives 19.5% Amid Job Scam Warning
By ATTN Desk · Editorial oversight: Sean Han
Molina Healthcare Inc. Overview
Molina Healthcare Inc. (NYSE: MOH) is a Fortune 500 company providing managed care services through government-sponsored programs, primarily Medicaid and Medicare. Headquartered in Long Beach, California, the company delivers health plans and care management to qualifying families and individuals across multiple U.S. states. Molina’s mission focuses on delivering effective and affordable health care to underserved populations while engaging with community partners to address social determinants of health.
Corporate Structure and Experience
With more than 10,001 employees, Molina Healthcare operates a network of primary care clinics and care management teams. The organization contracts directly with state governments to administer health plans that cover medical services including doctor visits, hospitalization, prescription drugs, and preventive services. Molina offers fully remote and hybrid roles, and maintains a comprehensive rewards program that addresses employees’ financial, physical, emotional, and social well-being.
Healthcare Services by Roma Kaiuk🇺🇦
Developments and News
On October 23, 2025, Molina Healthcare issued a warning to job seekers about a fraud scheme involving third parties posing as company recruiters who solicit money from candidates who have not participated in interviews. The company advised any individual receiving an unsolicited offer to contact for verification. This notice reflects Molina’s efforts to safeguard applicants and maintain trust in its hiring practices.
Financial and Strategic Analysis
As of October 23, 2025, Molina Healthcare shares closed at $157.00, reflecting a 19.54 percent decrease from the previous close. Trading volume reached 110,788 shares on the New York Stock Exchange. Key financial metrics for the trailing 12 months include:
- Revenue of $41.7 billion, with net income attributable to common shareholders totaling $1.13 billion, resulting in a profit margin of 2.71 percent.
- Diluted earnings per share (EPS) of $20.27, with a trailing price-to-earnings (P/E) ratio of 7.64 and a forward P/E of 9.68.
- Total cash on hand reported at $8.81 billion and a debt-to-equity ratio of 77.41 percent.
- Levered free cash flow of $512.38 million.
Market capitalization was approximately $8.39 billion during intraday trading, while enterprise value stood at $5.28 billion. Analysts assign a consensus Investment Rating of HOLD, with target prices ranging from $201 to $213. Molina's emphasis on Medicaid and community health initiatives aligns with its focus on government-sponsored care, though it remains subject to policy and reimbursement risks.
Market Position and Industry Context
Molina Healthcare specializes in the U.S. managed care market, focusing on Medicaid and Medicare beneficiaries. Its beta of 0.55 indicates lower volatility compared to broader indices, but the company's dependency on state funding renders it sensitive to regulatory changes. Unlike diversified insurers that provide various health services, Molina operates on a smaller scale primarily aligned with public-sector health programs. Community grants and partnerships aimed at addressing food insecurity and chronic disease education contribute to Molina’s engagement within the community. As the industry faces challenges such as rising medical costs and reimbursement pressures, Molina’s operational strategies and mission-driven approach play a crucial role in its positioning.
tl;dr
On October 23, 2025, Molina Healthcare shares fell to $157.00, down 19.54 percent in light of broader sector challenges. The company issued a fraud alert for job applicants regarding solicitations by imposters. Financial metrics indicate a trailing P/E of 7.64, revenue of $41.7 billion, and a HOLD rating with target prices near $207. Investors are awaiting Molina’s next earnings report scheduled for October 22, 2025, while monitoring state reimbursement policies and enrollment trends within its core Medicaid and Medicare segments.